These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23759507)

  • 1. Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery.
    Chilton CH; Freeman J; Baines SD; Crowther GS; Nicholson S; Wilcox MH
    J Antimicrob Chemother; 2013 Sep; 68(9):2078-82. PubMed ID: 23759507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
    Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
    J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.
    Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2008 Nov; 62(5):1078-85. PubMed ID: 18772161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production.
    Chilton CH; Crowther GS; Ashwin H; Longshaw CM; Wilcox MH
    PLoS One; 2016; 11(8):e0161200. PubMed ID: 27556739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.
    Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2009 Mar; 63(3):520-5. PubMed ID: 19112083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model.
    Chilton CH; Freeman J; Crowther GS; Todhunter SL; Wilcox MH
    J Antimicrob Chemother; 2012 Oct; 67(10):2434-7. PubMed ID: 22723601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.
    O'Connor R; Baines SD; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2008 Oct; 62(4):762-5. PubMed ID: 18606787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvacrol reduces Clostridium difficile sporulation and spore outgrowth in vitro.
    Mooyottu S; Flock G; Venkitanarayanan K
    J Med Microbiol; 2017 Aug; 66(8):1229-1234. PubMed ID: 28786786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro efficacy of sodium selenite in reducing toxin production, spore outgrowth and antibiotic resistance in hypervirulent Clostridium difficile.
    Pellissery AJ; Vinayamohan PG; Yin HB; Mooyottu S; Venkitanarayanan K
    J Med Microbiol; 2019 Jul; 68(7):1118-1128. PubMed ID: 31172910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germination response of spores of the pathogenic bacterium Clostridium perfringens and Clostridium difficile to cultured human epithelial cells.
    Paredes-Sabja D; Sarker MR
    Anaerobe; 2011 Apr; 17(2):78-84. PubMed ID: 21315167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germination efficiency of clinical Clostridium difficile spores and correlation with ribotype, disease severity and therapy failure.
    Moore P; Kyne L; Martin A; Solomon K
    J Med Microbiol; 2013 Sep; 62(Pt 9):1405-1413. PubMed ID: 23518657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of rhodomyrtone on Clostridium difficile vegetative cells and spores in vitro.
    Srisuwan S; Mackin KE; Hocking D; Lyras D; Bennett-Wood V; Voravuthikunchai SP; Robins-Browne RM
    Int J Antimicrob Agents; 2018 Nov; 52(5):724-729. PubMed ID: 30145248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed infection by Clostridium difficile in an in vitro model of the human gut.
    Baines SD; Crowther GS; Todhunter SL; Freeman J; Chilton CH; Fawley WN; Wilcox MH
    J Antimicrob Chemother; 2013 May; 68(5):1139-43. PubMed ID: 23354280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
    Rätsep M; Kõljalg S; Sepp E; Smidt I; Truusalu K; Songisepp E; Stsepetova J; Naaber P; Mikelsaar RH; Mikelsaar M
    Anaerobe; 2017 Oct; 47():94-103. PubMed ID: 28465256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new strategy for the prevention of Clostridium difficile infection.
    Howerton A; Patra M; Abel-Santos E
    J Infect Dis; 2013 May; 207(10):1498-504. PubMed ID: 23420906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambush of Clostridium difficile spores by ramoplanin: activity in an in vitro model.
    Kraus CN; Lyerly MW; Carman RJ
    Antimicrob Agents Chemother; 2015 May; 59(5):2525-30. PubMed ID: 25691641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the effect of supplementation on Clostridioides (Clostridium) difficile spore recovery in two solid agars.
    Pickering DS; Vernon JJ; Freeman J; Wilcox MH; Chilton CH
    Anaerobe; 2018 Apr; 50():38-43. PubMed ID: 29408598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hospital biocide sodium dichloroisocyanurate on the viability and properties of Clostridium difficile spores.
    Joshi LT; Welsch A; Hawkins J; Baillie L
    Lett Appl Microbiol; 2017 Sep; 65(3):199-205. PubMed ID: 28639362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
    Ochsner UA; Bell SJ; O'Leary AL; Hoang T; Stone KC; Young CL; Critchley IA; Janjic N
    J Antimicrob Chemother; 2009 May; 63(5):964-71. PubMed ID: 19251726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nisin is an effective inhibitor of Clostridium difficile vegetative cells and spore germination.
    Lay CL; Dridi L; Bergeron MG; Ouellette M; Fliss IL
    J Med Microbiol; 2016 Feb; 65(2):169-175. PubMed ID: 26555543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.